You searched for Antibody candidate - Page 68 of 69

News and Trends 5 Feb 2016

Biotech of the week: Effimune, the French Success-story in autoimmune disease

…with it’s primary focus on the research and development of drug candidates for transplant and immune-mediated diseases, making it one of the largest EU research and clinical centers in transplant…

February 5, 2016 - 2 minutesmins - By Philip Hemme

News and Trends 22 Jan 2018

Abcam Will Start Selling Over 700 Antibodies from Roche

…to over 500 other antibodies. And, as Spring continues developing new antibodies, the antibody seller will have the rights to all products that Roche decides to commercialize. For its part,…

January 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

How to Address the Challenges of Biologics Discovery and Development

…key market players enter the field, competition is increasing. In recent years, the biologics industry has become more versatile and has moved from being primarily antibody-focused to including other modalities,…

November 27, 2019 - 6 minutesmins - By External Contributor

News and Trends 12 Dec 2022

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

…to its dual mode of action comprising both antibody-dependent cellular phagocytosis induction and IL-7R-pathway blockade, OSE-127 may represent a promising novel immunotherapy option for ALL patients, including cases with dysregulated…

December 12, 2022 - 4 minutesmins - By Jim Cornall

Interview 6 Mar 2017

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

…use bicyclic peptides to guide toxins in an approach similar to antibody-drug conjugates (ADCs); and they stand to outperform their antibody-guided counterparts. Kevin Lee, CEO of Bicycle Therapeutics, sat down…

March 6, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 29 May 2020

Argenx Follows up Phase III Success with Giant €785M Global Offering

…III trial results earlier this week, where its lead candidate antibody drug, efgartigimod, improved motor symptoms of patients with the chronic autoimmune disease myasthenia gravis. Argenx is listed on the…

May 29, 2020 - 2 minutesmins - By Jonathan Smith

Best in Biotech 26 Dec 2017

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

…of approaches… https://www.labiotech.eu/tag/mrna-technology/ RNA saw its first major win in perhaps decades this year, with the positive Phase III results for Alnylam and Sanofi‘s candidate, patisiran. So how far has…

December 26, 2017 - 6 minutesmins - By Evelyn Warner

biotech investment asia pacific june 2022

In Depth 19 Jul 2022

The biggest Asia-Pacific biotech investments in June 2022

…using artificial intelligence (AI) and robotics to automate many research techniques including antibody selection, cell line development and molecular screening. “The global life sciences automation industry has significant growth potential,”…

July 19, 2022 - 3 minutesmins - By Jonathan Smith

Best in Biotech 7 Jan 2019

15 European Biotech Companies to Watch in 2019

…by its IPO, Orchard is planning to complete clinical development for its three lead gene therapy candidates and hopefully get them to the market. The company will also be pushing…

January 7, 2019 - 9 minutesmins - By Clara Rodríguez Fernández

llama leo pharma argen x skin milestone inflammatory

More News! 3 Apr 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The Belgian biotech AgomAb has raised €21M and partnered with the Dutch biotech argenx to develop antibody treatments that could regenerate damaged tissue. The round was led by the Belgian…

April 3, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 4 Sep 2018

The EMA Approves the First Nanobody from Ablynx

…nanobody — a single-domain antibody inspired by those of llamas and camels that combines the specificity of a full antibody with the advantages of having a significantly smaller size. After…

September 4, 2018 - 2 minutesmins - By Editorial Team

In Depth 13 Jul 2022

The biggest European biotech investments in June 2022

…million) in a Series C round to finance the development of antibody drugs that fight cancer by recruiting a type of immune cell called gamma delta T cells. “In a…

July 13, 2022 - 3 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

Biotech of the week: Effimune, the French Success-story in autoimmune disease

Abcam Will Start Selling Over 700 Antibodies from Roche

How to Address the Challenges of Biologics Discovery and Development

OSE Immunotherapeutics announces latest acute lymphoblastic leukemia data

How did this Biotech seal a €1B Deal with AstraZeneca? The CEO Explains

Argenx Follows up Phase III Success with Giant €785M Global Offering

Interviews, Reviews and Tops: Our Best Biotech Articles from 2017

The biggest Asia-Pacific biotech investments in June 2022

15 European Biotech Companies to Watch in 2019

€21M Series A to Finance Belgian Biotech’s Regenerative Antibodies

The EMA Approves the First Nanobody from Ablynx

The biggest European biotech investments in June 2022

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!